Does Platelet Transfusion Need Blood Grouping?
Platelet products must be ABO and Rh typed and labeled, but red cell cross-matching is not necessary because platelets contain few red cells. 1
ABO Typing Requirements
Platelet products are labeled with ABO and Rh typing as a standard requirement 1. However, the clinical implications differ significantly from red blood cell transfusions:
Why ABO Typing Matters for Platelets
- Platelets express ABO antigens on their surface, which can lead to accelerated clearance when incompatible with recipient antibodies 2
- Donor plasma contains ABO antibodies that can cause hemolysis of recipient red blood cells, particularly in children 1
- ABO-compatible products should be provided whenever possible, though inventory constraints may occasionally prevent this 1
Clinical Impact of ABO Compatibility
ABO-compatible platelets produce better transfusion outcomes. Studies demonstrate that ABO-mismatched transfusions can result in lower corrected count increments (CCI), especially after the first transfusion 3. Patients who develop elevated anti-A or anti-B isoagglutinin titers show consistently inferior responses to mismatched platelets 3, 4.
The risk of clinically significant hemolysis from ABO-incompatible plasma is unusual in adult recipients but poses greater risk in pediatric patients 1. When ABO-incompatible platelets must be used, plasma can be partially replaced with platelet additive solution (PAS) to reduce hemolysis risk 1.
Rh Typing Considerations
RhD-negative children (particularly girls) and women of childbearing age should receive RhD-negative platelets to prevent alloimmunization 5, 6. While platelets don't express Rh antigens, they contain small numbers of intact red blood cells or fragments that can cause RhD alloimmunization 2.
For RhD-negative patients receiving RhD-positive platelets, anti-D immunoprophylaxis should be considered 5.
Cross-Matching Is Not Required
Red cell cross-matching is not necessary for platelet transfusions because platelet products contain few red cells 1, 5, 1, 5. This distinguishes platelet transfusion from red blood cell transfusion and simplifies the compatibility testing process.
Special Circumstances: HLA Matching
For patients with alloimmune refractoriness to platelet transfusion (documented poor increments after at least two ABO-compatible transfusions stored <72 hours), HLA-A and HLA-B antigen-selected single-donor apheresis platelets should be used 1, 5. This requires HLA typing of the patient and selection of compatible donors, but this is distinct from routine ABO/Rh typing.
Common Pitfalls
- Don't assume ABO compatibility doesn't matter: While not as critical as for red cells, ABO matching improves platelet increments and should be pursued when feasible
- Don't forget Rh considerations in women and children: RhD alloimmunization can have significant future implications for pregnancy
- Don't order cross-matching: This wastes time and resources for platelet transfusions
- Monitor for hemolysis with ABO-incompatible transfusions: Particularly when transfusing group O platelets to non-O recipients 7